All Topics Biotechnology Biotech Business Biotech Products Cancer Cardiovascular Dermatology Drug Discovery Endocrinology Gastroenterology Immunology Infectious Diseases Mental Health Neurology Obstetrics Orthopedics Public Health Respiratory Rheumatology Urology Track topics on Twitter Track topics that are important to you
To develop Kineta's α9/α10 nicotinic acetylcholine receptor (nAChR) antagonists for the treatment of chronic pain
Original Article: Kineta, Genentech Enter Collaboration
Quick LinksAdvanced Search | Login | Subscribe | RSS
Pain Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...
Search Biotech, Medical and Healthcare News
Popular Biotech, Medical and Healthcare News
Biotech News by Article Type
BioPortfolio Bloggers
Publishing Your News on BioPortfolio
Recent Visitor News Searches